Related Experiment Video
Updated: Jan 22, 2026

Translational Orthotopic Models of Glioblastoma Multiforme
Published on: February 17, 2023
Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion
Lawrence Helson1, Muhammed Majeed2
1Consultant, Sabinsa Corporation, East Windsor, NJ, U.S.A. lhelson@comcast.net.
Abstract:
Current clinical failure to cure primary glioblastoma multiforme in virtually all adult patients is due to genetic aberrations, molecular heterogeneity, and clonal evolution of tumor stem and differentiated cells within the core tumor, leading to their migration, invasion and proliferation in normal surrounding and in distant cerebral tissue sites. These factors are the causes of targeted drug resistance, inadequate surgical removal, and inadequate radio-therapeutic interventions. Resolution of this clinical conundrum may be found in administration of Withaferin A alone or in combination with pleiotropic drugs which address aberrant molecules and pathways promoting tumor cell motility, migration, invasion and proliferation.
Insights
Glioblastoma multiforme (GBM) treatment fails due to tumor complexity and spread. Withaferin A may offer a new therapeutic strategy by targeting GBM cell invasion and proliferation.
Area of Science:
- Neuro-oncology
- Cancer Biology
- Pharmacology
Background:
- Primary glioblastoma multiforme (GBM) remains largely incurable in adult patients.
- Treatment failures stem from genetic aberrations, molecular heterogeneity, and clonal evolution within GBM.
- These factors contribute to drug resistance, incomplete surgical resection, and ineffective radiotherapy.
Purpose of the Study:
- To explore Withaferin A as a potential therapeutic agent for glioblastoma multiforme.
- To investigate the efficacy of Withaferin A, alone or in combination, in addressing GBM's aggressive characteristics.
Main Methods:
- The study focuses on the molecular mechanisms underlying GBM progression, including cell motility, migration, and invasion.
- It proposes the use of Withaferin A and pleiotropic drugs to counteract these mechanisms.
Main Results:
- Withaferin A and combination therapies show promise in targeting pathways that promote tumor cell motility, migration, invasion, and proliferation.
- These agents may overcome key challenges leading to current clinical treatment failures.
Conclusions:
- Withaferin A presents a potential therapeutic avenue for glioblastoma multiforme.
- Combination therapies targeting aberrant molecules and pathways could improve treatment outcomes for GBM.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Migration
Cell Migration
Cell Migration
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

